Subgenomic replicon systems are engineered flavivirus RNA constructs that retain replication machinery but lack structural genes, preventing virus production. These systems serve as a valuable tool for antiviral screening, allowing researchers to study viral replication in a controlled setting. By testing potential inhibitors on replicon-expressing cells, researchers can identify compounds that disrupt viral RNA replication without handling infectious virus, making this approach both efficient and biosafety-compliant.